Agammaglobulinemia News and Research

RSS
Convalescent plasma in COVID-19 can be effective, especially early in disease

Convalescent plasma in COVID-19 can be effective, especially early in disease

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

COVID-19 and immunodeficiency

COVID-19 and immunodeficiency

When an insurer balks and treatment stops

When an insurer balks and treatment stops

Researchers find method to repair gene mutation causing autoimmune deficiency disease

Researchers find method to repair gene mutation causing autoimmune deficiency disease

Scientists solve a decades-long mystery of cell biology

Scientists solve a decades-long mystery of cell biology

New insights into how body's innate immunity is triggered to create effective immune response

New insights into how body's innate immunity is triggered to create effective immune response

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

New way to study proteins in live cells

New way to study proteins in live cells

X-linked agammaglobulinemia

X-linked agammaglobulinemia